1. Home
  2. CTKB vs VREX Comparison

CTKB vs VREX Comparison

Compare CTKB & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • VREX
  • Stock Information
  • Founded
  • CTKB 1990
  • VREX 2016
  • Country
  • CTKB United States
  • VREX United States
  • Employees
  • CTKB N/A
  • VREX N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • VREX Industrial Machinery/Components
  • Sector
  • CTKB Health Care
  • VREX Technology
  • Exchange
  • CTKB Nasdaq
  • VREX Nasdaq
  • Market Cap
  • CTKB 718.8M
  • VREX 576.8M
  • IPO Year
  • CTKB 2021
  • VREX N/A
  • Fundamental
  • Price
  • CTKB $4.00
  • VREX $11.52
  • Analyst Decision
  • CTKB Buy
  • VREX Strong Buy
  • Analyst Count
  • CTKB 2
  • VREX 2
  • Target Price
  • CTKB $7.00
  • VREX $22.50
  • AVG Volume (30 Days)
  • CTKB 957.9K
  • VREX 334.7K
  • Earning Date
  • CTKB 05-07-2025
  • VREX 05-01-2025
  • Dividend Yield
  • CTKB N/A
  • VREX N/A
  • EPS Growth
  • CTKB N/A
  • VREX N/A
  • EPS
  • CTKB N/A
  • VREX N/A
  • Revenue
  • CTKB $200,453,000.00
  • VREX $820,800,000.00
  • Revenue This Year
  • CTKB $6.66
  • VREX $4.03
  • Revenue Next Year
  • CTKB $9.54
  • VREX $3.32
  • P/E Ratio
  • CTKB N/A
  • VREX N/A
  • Revenue Growth
  • CTKB 3.85
  • VREX N/A
  • 52 Week Low
  • CTKB $3.98
  • VREX $10.19
  • 52 Week High
  • CTKB $7.63
  • VREX $18.30
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 32.03
  • VREX 30.15
  • Support Level
  • CTKB $4.03
  • VREX $12.40
  • Resistance Level
  • CTKB $4.41
  • VREX $12.78
  • Average True Range (ATR)
  • CTKB 0.18
  • VREX 0.44
  • MACD
  • CTKB 0.03
  • VREX -0.07
  • Stochastic Oscillator
  • CTKB 4.21
  • VREX 0.00

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About VREX Varex Imaging Corporation

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.

Share on Social Networks: